Entities / Company
Cyclacel.
company in Berkeley Heights, United States
- Reports this week
- 2
- Active events
- 1
- Connections
- 11
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Cyclacel must file an amendment with the Secretary of State regarding its corporate status in Delaware.Some support2 reports
-
Cyclacel shares began trading on the Nasdaq Capital Market on July 3, 2025.Speculative1 report
-
Cyclacel is highlighting research into Fibrolamellar Cancer (FLC), noting that FLC is frequently misdiagnosed as Hepatocellular Carcinoma (HCC).Speculative1 report
-
Cyclacel entered into an amendment with Fitters Diversified Berhad, maintaining Fitters Sdn. Bhd. as a wholly-owned subsidiary.Speculative1 report
-
Cyclacel highlighted a study originating from Kuala Lumpur, Malaysia.Some support2 reports
-
Cyclacel reported its financial results in Kuala Lumpur, Malaysia.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Cyclacel this week
News at the entities that move Cyclacel most-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Cyclacel
-
Malaysia Shared contextMIFF is based in Kuala Lumpur.Moves Cyclacel
Connections
The 2 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
MarketBeat Mentioned together
MarketBeat publishes consensus ratings and market coverage regarding Cyclacel.
-
Malaysia Shared context
Cyclacel conducts its operations and reports financial results within the geographical context of Malaysia.
History
Events by the month they beganSeptember 2026
1 eventJuly 2026
1 eventJune 2026
6 events- Cyclacel must file an amendment with the Secretary of State regarding its corporate status in Delaware.
- Cyclacel shares began trading on the Nasdaq Capital Market on July 3, 2025.
- Cyclacel is highlighting research into Fibrolamellar Cancer (FLC), noting that FLC is frequently misdiagnosed as Hepatocellular Carcinoma (HCC).
- Cyclacel entered into an amendment with Fitters Diversified Berhad, maintaining Fitters Sdn. Bhd. as a wholly-owned subsidiary.
- Cyclacel highlighted a study originating from Kuala Lumpur, Malaysia.
- Cyclacel reported its financial results in Kuala Lumpur, Malaysia.